Coty Inc. Form 10-K Summary
Reporting period: The filing covers fiscal 2022, the year ended June 30, 2022—not fiscal 2021. It also reports the quarter ended June 30, 2022, which is fiscal Q4 2022. All dollar amounts below are in millions unless stated otherwise.
Business context
Coty sells prestige and consumer beauty products, including fragrances, color cosmetics, and skin and body care, in approximately 125 countries. Its reportable segments are Prestige and Consumer Beauty. The Wella professional and retail hair business is presented as discontinued operations; Coty retained a 25.9% equity interest in Wella at June 30, 2022.
Financial performance
| Metric | FY 2022 | FY 2021 |
|---|---|---|
| Net revenue | $5,304.4 | $4,629.9 |
| Gross profit / gross margin | $3,369.2 / 63.5% | $2,768.2 / 59.8% |
| Operating income (loss) from continuing operations | $240.9 / 4.5% margin | $(48.6) / (1.0)% margin |
| Adjusted operating income (non-GAAP) | $615.5 / 11.6% margin | $436.2 / 9.4% margin |
| Adjusted EBITDA (non-GAAP) | $905.3 / 17.1% margin | $762.0 / 16.5% margin |
| Net income (loss) attributable to Coty Inc. | $259.5 | $(201.3) |
| Net income attributable to common stockholders from continuing operations; diluted EPS | $55.5; $0.07 | $(166.3); $(0.22) |
| Cash from operating activities | $726.6 | $318.7 |
| Cash and cash equivalents at year-end | $233.3 | $253.5 |
| Total debt, net of discount, at year-end | $4,473.9 | $5,476.9 |
Revenue grew 15%: Prestige increased 20% to $3,267.9, and Consumer Beauty increased 7% to $2,036.5. Coty attributed growth to store reopenings, travel retail recovery, launches, pricing and mix, and e-commerce. Fiscal Q4 2022 revenue was $1,168.3 versus $1,062.4 in Q4 2021; Q4 operating loss was $77.4 and net loss attributable to Coty Inc. was $281.5.
Gross margin expanded approximately 370 basis points, reflecting favorable category mix, price increases, manufacturing efficiencies, and lower inventory obsolescence, partly offset by approximately 120 basis points of inflationary cost pressure. SG&A rose 22% to $2,881.3, driven principally by higher advertising and promotional spending, CEO-related stock compensation, and Russia-exit costs. FY 2022 net income also included $409.9 of other income, primarily a $403.9 unrealized gain on the Wella investment; this materially affected reported earnings.
Cash, debt, and liquidity
Operating cash flow more than doubled year over year. Investing activities provided $269.7, including $230.6 of returns of capital from Wella; financing activities used $1,034.0, primarily reflecting debt repayments. Capital expenditures were $174.1. Coty reported $4,498.5 of total debt before discounts and fees and $4,473.9 net of discount at year-end, with $233.3 cash. It refinanced its revolving facilities into a $2,000 facility due in 2025, issued $500 of 4.75% secured notes due 2029, and redeemed €550 million of 2023 euro notes. The company stated it was in compliance with its debt covenants at June 30, 2022.
Common-stock dividends remained suspended. Coty expected to continue cash dividends on Series B preferred stock, subject to Board declaration. The filing says the company expects common dividends to remain suspended until net debt to Adjusted EBITDA reaches 2x.
Material changes, outlook, and risks
- Outlook: Management expected fiscal 2023 reported net revenue growth in the mid-single digits, excluding foreign-exchange effects. It expected inflationary pressure to increase in certain markets and continue into FY 2023; planned price increases and other mitigations might not fully offset it. The Transformation Plan was expected to be completed by the end of FY 2023, with further savings initiatives in FY 2024.
- Russia exit: Coty recorded $83.6 of pre-tax charges and $24.1 of tax charges related to winding down its Russian subsidiary. It anticipated up to $10.0 of additional costs and future net cash costs of $40–$45, to be funded by the subsidiary. The wind-down remained at an early stage.
- Wella investment and preferred stock: Coty received $230.6 in Wella distributions and used them to repay debt. It exchanged portions of its Wella stake to redeem or convert KKR’s Series B preferred stock; KKR no longer held Coty preferred stock or director designation rights at year-end. Wella was valued at $830.0 using Level 3 inputs, making valuation assumptions a key source of uncertainty.
- Other notable items: Coty recorded $115.5 of gains on real estate sales and $31.4 of impairment charges on indefinite-lived trademarks, including Max Factor and Bourjois. Max Factor and Bourjois had no valuation cushion after impairment; the filing describes potential additional impairment sensitivity to lower revenue or higher discount rates. Stock-based compensation rose to $195.5, largely due to the CEO award.
- Key risks and contingencies: Inflation, supply-chain and labor constraints, COVID-related restrictions in China, foreign-exchange and interest-rate movements, substantial debt and covenant limits, licensed-brand dependence, competitive and channel shifts, and execution of the transformation strategy could affect results. Legal matters include a pending Cottage Tender Offer stockholder action and Brazilian tax assessments; the company stated it had not recorded a loss for the assessments because it did not consider a loss probable. The filing also describes talc-related product litigation and other legal and compliance risks.
Important facts for investors to verify
- Review the reconciliation of GAAP income to adjusted operating income, EBITDA, and adjusted net income; FY 2022 earnings included a large unrealized Wella valuation gain and real-estate gains.
- Track the Russia wind-down’s remaining costs and cash outflows, and whether inflation, supply constraints, and pricing actions affect margins and the FY 2023 revenue outlook.
- Assess debt maturities, variable-rate exposure, covenant headroom, available revolving capacity, and progress toward management’s deleveraging target.
- Monitor Wella’s Level 3 valuation assumptions, distributions, and any contingent Wella sale proceeds; $33.3 of an advance remained unearned at year-end and was subject to clawback conditions.
- Check impairment assumptions for Max Factor and Bourjois, and developments in Brazilian tax assessments and material litigation.
- Consider the suspended common dividend, Series B preferred-stock obligations, and the influence of the majority stockholder, which owned approximately 54% of outstanding Class A shares.